Literature DB >> 21849778

Search for a map and threshold in perfusion MRI to accurately predict tissue fate: a protocol for assessing lesion growth in patients with persistent vessel occlusion.

Ivana Galinovic1, Ann-Christin Ostwaldt, Carina Soemmer, Helena Bros, Benjamin Hotter, Peter Brunecker, Wolf U Schmidt, Jan Jungehülsing, Jochen B Fiebach.   

Abstract

BACKGROUND: The MRI-based mismatch concept has been used to estimate the risk of infarction in ischemic stroke. Based on multiple studies on magnetic resonance perfusion imaging, it seems unlikely that any perfusion parameter threshold will provide a reliable prediction of radiological or clinical outcome for all patients. The goal of our study was to find a minimally biased yet maximally useful perfusion postprocessing protocol which would offer the treating physician a useful estimate of tissue fate.
METHODS: One hundred and forty-five acute ischemic stroke patients, admitted within 24 h after stroke to the Charité-University Medicine Hospital in Berlin between March 2008 and November 2009, were included in this study. Using three different software packages (Perfscape/Neuroscape, PMA and Stroketool), maps of mean transit time, cerebral blood flow (CBF) and T(max) were created. Three different thresholds were applied on each parameter map and subsequent volumes of hypoperfused tissue were calculated.
RESULTS: Overall, the maps and thresholds giving the least amount of overestimation of the final infarct volume were T(max) 8 s in Perfscape/Neuroscape, CBF 20 ml/100 g/min in PMA and CBF 15% (of the highest value on the scale for a given patient) in Stroketool. In patients with persistent vessel occlusion, a CBF map with a restrictive threshold showed volumes of tissue at definite risk of infarction in up to 100% of patients. The additional use of a CBF map with a high threshold enabled identification of patients without penumbras.
CONCLUSIONS: No combination of software, map and threshold was able to give a reliable estimate of tissue fate for either all patients or any subgroup of patients. However, in patients with vessel occlusion, combination of a CBF map with a low and a high threshold can enable calculation of the minimum volume of brain tissue that will inevitably be lost if the occlusion persists.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21849778     DOI: 10.1159/000328663

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

1.  Clinically relevant reperfusion in acute ischemic stroke: MTT performs better than Tmax and TTP.

Authors:  Andria L Ford; Hongyu An; Linglong Kong; Hongtu Zhu; Katie D Vo; William J Powers; Weili Lin; Jin-Moo Lee
Journal:  Transl Stroke Res       Date:  2014-02-06       Impact factor: 6.829

2.  Optimising MR perfusion imaging: comparison of different software-based approaches in acute ischaemic stroke.

Authors:  Lars-Arne Schaafs; David Porter; Heinrich J Audebert; Jochen B Fiebach; Kersten Villringer
Journal:  Eur Radiol       Date:  2016-02-06       Impact factor: 5.315

Review 3.  Refining the mismatch concept in acute stroke: lessons learned from PET and MRI.

Authors:  Jan Sobesky
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-18       Impact factor: 6.200

4.  Effects of salvianolic acid on cerebral perfusion in patients after acute stroke: A single-center randomized controlled trial.

Authors:  Jian-Wei Peng; Yuan Liu; Gai Meng; Jin-Yan Zhang; Lian-Fang Yu
Journal:  Exp Ther Med       Date:  2018-07-16       Impact factor: 2.447

5.  Automated vs manual delineations of regions of interest- a comparison in commercially available perfusion MRI software.

Authors:  Ivana Galinovic; Ann-Christin Ostwaldt; Carina Soemmer; Helena Bros; Benjamin Hotter; Peter Brunecker; Jochen B Fiebach
Journal:  BMC Med Imaging       Date:  2012-07-18       Impact factor: 1.930

6.  The ratio between cerebral blood flow and Tmax predicts the quality of collaterals in acute ischemic stroke.

Authors:  Ivana Galinovic; Elena Kochova; Ahmed Khalil; Kersten Villringer; Sophie K Piper; Jochen B Fiebach
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.